Sam Altman’s Neuralink competitor Merge Labs is taking shape with a key hire that suggests a fundamentally different approach to brain-computer interfaces. The company appears to be pursuing non-invasive methods using gene therapy and ultrasound technology.
Sam Altman is co-founding Merge Labs, a brain-computer interface startup that will use ultrasound and gene therapy for less invasive neural interfaces. The company represents a direct competitor to Elon Musk’s Neuralink with a fundamentally different technical approach.
Revolutionizing Metal 3D Printing with Ultrasonic Enhancement In a groundbreaking advancement for metal additive manufacturing, researchers have developed a dual-laser…
